A Single-arm Open-label Phase II Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
Latest Information Update: 11 Apr 2024
At a glance
- Drugs SYHX 2011 (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- Sponsors CSPC Ouyi Pharmaceutical
Most Recent Events
- 11 Apr 2024 New trial record